Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series

1. Ruiz-Villaverde, R.
2. Dominguez-Cruz, J.
3. Armario-Hita, J.C.
4. Martinez-Pilar, L.
5. Alcantara-Luna, S.
6. Pereyra-Rodriguez, J.J.